VERA THERAPEUTICS INC's ticker is VERA and the CUSIP is 92337R101. A total of 96 filers reported holding VERA THERAPEUTICS INC in Q4 2023. The put-call ratio across all filers is 4.87 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $213,715 | +968.1% | 5,907 | +1173.1% | 0.00% | – |
| Q1 2024 | $20,008 | -84.3% | 464 | -94.4% | 0.00% | -100.0% |
| Q4 2023 | $127,577 | +297.8% | 8,295 | +254.6% | 0.00% | +100.0% |
| Q3 2023 | $32,068 | +3.6% | 2,339 | +21.3% | 0.00% | 0.0% |
| Q2 2023 | $30,944 | +81331.6% | 1,928 | -60.1% | 0.00% | 0.0% |
| Q1 2023 | $38 | +280.0% | 4,834 | +810.4% | 0.00% | – |
| Q4 2022 | $10 | -100.0% | 531 | -65.4% | 0.00% | -100.0% |
| Q3 2022 | $33,000 | +73.7% | 1,535 | +7.3% | 0.00% | – |
| Q2 2022 | $19,000 | +280.0% | 1,430 | +530.0% | 0.00% | – |
| Q1 2022 | $5,000 | -64.3% | 227 | -57.8% | 0.00% | – |
| Q4 2021 | $14,000 | +40.0% | 538 | -11.1% | 0.00% | – |
| Q3 2021 | $10,000 | – | 605 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| COMMODORE CAPITAL LP | 5,450,000 | $74,719,500 | 8.73% |
| Kynam Capital Management, LP | 2,956,053 | $40,527,487 | 6.63% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 758,355 | $10,381,880 | 3.50% |
| Sofinnova Investments, Inc. | 3,467,156 | $47,534,709 | 3.00% |
| Altium Capital Management LP | 333,681 | $4,574,767 | 2.39% |
| Eversept Partners, LP | 1,478,489 | $20,270,084 | 1.72% |
| SECTORAL ASSET MANAGEMENT INC | 357,139 | $4,896,376 | 0.95% |
| Carlyle Group Inc. | 1,438,155 | $19,688,342 | 0.85% |
| Orbimed Advisors | 1,518,115 | $20,813,357 | 0.44% |
| Woodline Partners LP | 2,562,600 | $35,133,246 | 0.41% |